Novartis-backed Neurovance bags $6.3M to focus on ADHD

Published April 14, 2014

Novartis-backed Neurovance bags .3M to focus on ADHD
"If we can demonstrate a lower risk of abuse potential versus d-amphetamine in the upcoming HAL study, EB-1020 may one day offer the best of both classes of drugs with stimulant-like efficacy but with a scheduling profile closer to that of the … Read more on FierceBiotech

Dad Sues State After 18 Month-Old Daughter Dies In Meth House
In a lawsuit filed last month, Watters claims DCF was informed that Jayla was being abused and did nothing to protect her. Court documents allege the state took child support payments from Watters, which allowed Alyssa Haag to continue her meth habit … Read more on WIBW

Take Back Program looks especially for most commonly abused drugs
Stimulants used for Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy include Dextroamphetamine or Dexedrine; Methylphenidate or Ritalin and Concerta; and Amphetamines or Adderall. Long-term use of opioids or central nervous system … Read more on Crossville Chronicle